| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.39 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.34 | 0.02 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.25 | 0.06 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-08 |